Skip to main content
. 2022 Oct 12;5(10):e2236298. doi: 10.1001/jamanetworkopen.2022.36298

Figure. Association Between Modality and 90-Day Retention Among VHA Patients Who Received Buprenorphine Following COVID-19–Related Changes.

Figure.